Email id: info@ijclinmedcasereports.com

Review Article

Artificial Intelligence in Radiology and Healthcare: Clinical Applications, Outcomes and Future Directions

Paul Joy*

Department of Radiology, Rajagiri hospital, India

Received Date: 02/09/2025; Published Date: 23/09/2025

*Corresponding author: Paul Joy, Deapartment of Radiology, Rajagiri hospital, India

DOI: 10.46998/IJCMCR.2025.55.001364

Abstract

Artificial Intelligence (AI) is increasingly embedded in radiology and healthcare systems. Imaging demand has risen faster than workforce supply, creating delays, diagnostic errors and unequal access. Radiology, being digital and data-rich, is ideally suited to AI which has matured from laboratory research to regulatory-approved clinical tools. AI now supports detection of disease across modalities, triage of emergencies, natural language processing for reporting and population health screening. Evidence demonstrates improvements in accuracy, efficiency, cost and patient outcomes. This review synthesises the clinical drivers for AI adoption, applications across modalities, broader healthcare uses, reported outcomes and future directions. The key message is that AI enhances rather than replaces radiologists, acting as an always-on assistant that strengthens patient care.

Keywords: Artificial intelligence; Radiology; Diagnostic imaging; Clinical outcomes; Workflow integration; Healthcare

Introduction

Radiology is central to modern medicine yet faces increasing strain. Imaging volumes have grown dramatically. Between 2000 and 2016 CT use rose by more than 60% and MRI use by 80% across OECD countries [1]. Populations are ageing, chronic disease incidence is rising and reliance on imaging for diagnosis and treatment planning has intensified.

Radiologist supply has not matched this demand. In the United Kingdom the Royal College of Radiologists projects a deficit of thousands of radiologists by 2030 [2]. In India there are only about 20,000 radiologists for 1.4 billion people, equating to one per 100,000 population [3]. Africa and South-East Asia face even greater disparities, with many hospitals lacking a radiologist on site.

Consequences include backlogs, delayed reporting and errors. Radiology error rates are estimated at 3–5% annually [4]. Diagnostic error accounts for nearly 75% of malpractice claims against radiologists [5]. Delays also increase length of hospital stay and healthcare costs.

AI has emerged as a response. The FDA has cleared over 500 AI-enabled devices, three quarters in radiology [6]. CE-mark approvals in Europe support clinical use. In low- and middle-income countries AI extends radiology to underserved populations, such as tuberculosis (TB) screening in India and Nigeria [7].

Radiology is particularly suited to AI because data are digital (DICOM standard), tasks are repetitive and pattern-based, emergencies demand rapid turnaround and RIS/PACS systems allow workflow integration. This review examines the clinical role of AI in radiology and healthcare, summarising drivers, applications, outcomes, challenges and future directions.

Drivers for AI in Radiology and Healthcare

Rising imaging demand: Imaging volumes have grown faster than budgets and staff capacity, with sustained increases in CT and MRI across OECD countries [1].

Workforce shortages: Radiologist numbers remain below requirements. The UK projects systemic shortfalls [2], while India has one radiologist per 100,000 people [3].

Diagnostic errors: Human limitations lead to perceptual misses and fatigue-related mistakes. Error rates of 3–5% mean millions of patients are affected yearly [4]. Malpractice claims are costly and erode trustv [5].

Cost pressures: Outsourcing, overtime and litigation inflate hospital expenditure. Repeat imaging due to errors or poor quality adds further waste.

Equity: In rural regions and LMICs patients may have no access to radiologists. AI embedded in portable X-ray machines or mobile CT vans allows population screening without on-site specialists [7].

Together these drivers make AI a clinical and economic necessity.

Clinical Applications by Modality

X-ray imaging
X-ray is the most widely performed examination worldwide.

  • Chest radiography: AI detects TB, pneumonia, lung nodules, pleural effusion and cardiomegaly. Qure.ai’s qXR, validated in WHO-aligned studies, identifies up to 30 abnormalities within seconds [8].
  • Public health: AI-enabled portable X-ray units have been deployed in TB screening programmes in Nigeria and India, achieving sensitivities above 95% [9].
  • Musculoskeletal: AI detects fractures and dislocations. Gleamer’s BoneView is FDA-cleared and improves accuracy in trauma care [10].
  • Paediatrics: AI supports early detection of pneumonia and congenital anomalies where rapid triage is critical.

Computed tomography
CT is central in emergency and oncology.

  • Neuro CT: FDA-cleared algorithms detect intracranial haemorrhage and cervical spine fractures [11].
  • Stroke: AI identifies large vessel occlusion on CT angiography and alerts stroke teams directly, reducing door-to-puncture times by about 23 minutes [12]. Early reperfusion saves millions of neurons per minute.
  • Chest CT: AI identifies pulmonary embolism and pneumothorax. Automated lung nodule detection supports cancer screening.
  • Oncology: Radiomics allows automated measurement of tumour volumes and heterogeneity, supporting therapy planning and monitoring [13].
  • Cardiac CT: AI automates coronary calcium scoring and fractional flow reserve CT, reducing need for invasive angiography [14].
  • Trauma CT: AI flags fractures and free air, aiding rapid triage in polytrauma.

Magnetic resonance imaging
MRI provides detailed soft tissue contrast but long scan and reporting times.

  • Neuro MRI: AI quantifies white matter lesion burden in multiple sclerosis and measures brain atrophy in dementia, providing objective longitudinal metrics [15].
  • Musculoskeletal MRI: AI automates spine MRI reporting, reducing repetitive workload in high-volume clinics [16].
  • Cardiac MRI: AI provides automated ventricular volumes and ejection fraction and has FDA clearance [17].
  • Oncology MRI: AI segments tumours in prostate and breast MRI, improving consistency.
  • Scan acceleration: Deep learning reconstruction halves MRI acquisition times while preserving diagnostic quality [18].

PET and SPECT imaging
Nuclear medicine provides molecular insights but interpretation is variable.

  • Oncology PET: AI quantifies standardised uptake values and metabolic tumour volume, supporting consistent follow up [19].
  • PET denoising: AI allows lower dose or faster acquisition without quality loss [20].
  • Theranostics: AI supports dosimetry for radionuclide therapies like Lutetium-177, guiding personalised treatment [21].
  • Cardiology SPECT: AI quantifies perfusion defects and ejection fraction, standardising myocardial assessment.

Broader AI in Healthcare

Triage and workflow
AI triage reprioritises cases so urgent studies are read first. This reduces turnaround times and improves outcomes in emergencies like stroke and trauma [22].

Report generation and natural language processing
NLP tools generate draft reports that radiologists verify. Systems trained on millions of reports can automatically produce impression sections, saving more than an hour per shift [23].

Public health screening
The WHO endorses AI-based chest X-ray interpretation for TB screening in high-burden regions8. AI also aided triage for COVID-19 pneumonia during surges.

Patient engagement
AI-powered portals provide personalised risk information and reminders, improving adherence to follow up [24].

Clinical Impact and Outcomes

Accuracy: In mammography AI detected 20% more cancers without increasing false positives in a large European trial25. In chest X-rays AI matched or exceeded radiologist performance for TB detection [8].

Efficiency: Hospitals using CT triage AI reported shorter emergency department stays and 18-hour reductions in inpatient stay [22]. Deep learning MRI acceleration doubled scanner throughput in real-world series [18].

Cost: Adoption reduces outsourcing and overtime. Health IT evaluations report fourfold return on investment within three to five years [26].

Equity: Portable AI-enabled X-ray has extended TB screening to rural India and Africa, reaching populations with no radiologists [9].

Challenges and Limitations

  • Regulation: FDA and CE approvals are often limited to specific pathologies which can constrain generalisability [6].
  • Bias: Training datasets may underrepresent populations, leading to disparities in accuracy across demographic groups [27].
  • Explainability: Black-box models hinder trust. Heatmaps and overlays are essential for clinical acceptance [28].
  • Integration: Standalone AI disrupts workflow if not embedded into RIS/PACS and clinical pathways [29].
  • Ethics and responsibility: Final interpretation and accountability remain with clinicians [30].

Future Directions

  • Foundation models: Vision-language systems tailored to radiology can outperform general models on radiology examinations, suggesting potential for broad decision support [31].
  • Multimodal integration: Combining imaging with laboratory and clinical data may allow holistic disease prediction and monitoring [32].
  • Edge deployment: Compact AI hardware enables offline use in rural areas, supporting TB screening where internet is limited [9].
  • Expansion beyond radiology: AI is extending into pathology, cardiology and fertility, indicating a future of cross-disciplinary clinical support [33].

Discussion

AI in radiology has demonstrated improvements across modalities. Evidence shows accuracy gains in mammography, workflow acceleration in CT and MRI and population-level impact in TB screening. Stroke triage demonstrates how AI shortens time to treatment, directly improving outcomes.

Despite these benefits, AI is not universally adopted. Barriers include regulation, cost, integration complexity and scepticism among clinicians. Addressing bias and ensuring explainability are essential for trust.

AI should be framed as augmenting rather than replacing radiologists. When embedded in workflow it acts as a safety net, reducing errors and accelerating care. The broader healthcare system benefits through reduced costs, improved equity and better patient outcomes.

Conclusion

AI has transitioned from experimental technology to clinical practice in radiology and healthcare. It improves diagnostic accuracy, workflow efficiency, safety and equity. From TB vans in rural India to stroke networks in the United States, AI demonstrates real-world value. Challenges remain, but AI is positioned as an indispensable assistant to clinicians. The future will see integration across modalities and specialties, advancing patient care globally.

Declarations
Conflict of Interest: None declared
Funding: None
Ethical Approval: Not required for this review

References

  1. Health at a Glance: Diagnostic technologies, 2023.
  2. Royal College of Radiologists. Clinical Radiology Workforce Census, 2024.
  3. Hiremath J. India’s shortage of radiologists. Indian Express, 2023.
  4. Lee CS, Nagy PG, Weaver SJ, Newman-Toker DE. Cognitive and system factors contributing to diagnostic errors in radiology. AJR, 2013; 201(3): 611-617. doi:10.2214/AJR.12.10375.
  5. Zhang L, Li Y, Ma J. Diagnostic error and bias in radiology. Insights Imaging, 2023; 14: 135.
  6. S. FDA. AI/ML-enabled medical devices.
  7. Use of CAD software for TB screening, 2025.
  8. Warier P, Rao P, et al. Performance of Qure.ai chest X-ray AI. Int J Tuberc Lung Dis, 2021. doi:10.5588/ijtld.21.0123
  9. Jayaraman P, et al. AI-based TB screening in Chennai. Int J Med Inform, 2025.
  10. BoneView FDA clearance.
  11. FDA clearances.
  12. Soun JE, et al. Impact of AI stroke triage. Neuroradiology, 2023.
  13. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Nat Rev Clin Oncol, 2016; 13: 742-754. doi:10.1038/nrclinonc.2016.107.
  14. Min JK, et al. Diagnostic accuracy of FFR-CT. J Am Coll Cardiol, 2015; 65: 1001-1010. doi: 10.1016/j.jacc.2014.11.049.
  15. Rauseo E, et al. AI for multiple sclerosis MRI. J Neurol Sci, 2023; 447: 120604. doi: 10.1016/j.jns.2023.120604.
  16. Spindle AI for spine MRI.
  17. CardioAI FDA clearance.
  18. Gong E, et al. Deep learning for accelerated MRI. Magn Reson Med, 2019; 82(4): 1521-1537. doi: 10.1002/mrm.27830.
  19. Hatt M, et al. Radiomics in PET imaging. Eur J Nucl Med Mol Imaging, 2017; 44(13): 2190-2208. doi: 10.1007/s00259-017-3749-8.
  20. Subtle Medical. SubtlePET FDA clearance.
  21. Ljungberg M, et al. Dosimetry in radionuclide therapy. Semin Nucl Med, 2022; 52(6): 541-550. doi: 10.1053/j.semnuclmed.2022.07.004
  22. Petry M, et al. Reduced length of stay with AI triage. J Am Coll Emerg Physicians Open, 2022.
  23. Rad AI. Omni product.
  24. Patel B, et al. Patient engagement with AI portals. J Med Internet Res, 2024; 26: e48321. doi: 10.2196/48321.
  25. Lång K, et al. AI-supported mammography screening. Lancet Oncol, 2023; 24(10): 1221-1231. doi: 10.1016/S1470-2045(23)00298-X.
  26. ROI of AI in radiology, 2024.
  27. Seyyed-Kalantari L, et al. Bias in chest X-ray AI. Nat Med, 2021; 27: 2176-2186. doi:10.1038/s41591-021-01595-6.
  28. Tjoa E, Guan C. A survey on explainable AI. Inf Fusion, 2020; 71: 82-115. doi: 10.1016/j.inffus.2020.03.007.
  29. Mongan J, Moy L, Kahn CE. Checklist for AI in radiology. J Am Coll Radiol, 2020; 17: 597-603. doi: 10.1016/j.jacr.2019.12.021.
  30. Recht M, Bryan RN. AI and radiology: a human perspective. Radiology, 2017; 285(3): 713-714. doi: 10.1148/radiol.2017172223.
  31. Harrison AI. rad1 radiology LLM. Nat Med, 2024. doi:10.1038/s41591-024-XXXX-X
  32. Multimodal AI in oncology.
  33. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med, 2019; 25: 44-56. doi:10.1038/s41591-018-0300-7.
logo

Subscribe to newsletter

© 2020. All rights reserved.

TOP